Observations from the OMERACT Drug Safety Summit, May 2008

Lee S. Simon, C. Vibeke Strand, Maarten Boers, Peter M. Brooks, David Henry, Peter S. Tugwell

Research output: Contribution to journalArticleResearchpeer-review

6 Citations (Scopus)

Abstract

Due to mounting concern about determination of benefit and risk in the context of product development and clinical practice the OMERACT Executive identified the need to bring together a variety of specialists to define risk. At the Drug Safety Summit held at OMERACT 9, specialists spoke on their given topics and the group considered risk in the context of formally posed questions. The Journal of Rheumatology

Original languageEnglish
Pages (from-to)2110-2113
Number of pages4
JournalJournal of Rheumatology
Volume36
Issue number9
DOIs
Publication statusPublished - Sep 2009
Externally publishedYes

Fingerprint

Safety
Rheumatology
Pharmaceutical Preparations

Cite this

Simon, L. S., Strand, C. V., Boers, M., Brooks, P. M., Henry, D., & Tugwell, P. S. (2009). Observations from the OMERACT Drug Safety Summit, May 2008. Journal of Rheumatology, 36(9), 2110-2113. https://doi.org/10.3899/jrheum.090590
Simon, Lee S. ; Strand, C. Vibeke ; Boers, Maarten ; Brooks, Peter M. ; Henry, David ; Tugwell, Peter S. / Observations from the OMERACT Drug Safety Summit, May 2008. In: Journal of Rheumatology. 2009 ; Vol. 36, No. 9. pp. 2110-2113.
@article{2588d24f3a9e474e921db290c7986b01,
title = "Observations from the OMERACT Drug Safety Summit, May 2008",
abstract = "Due to mounting concern about determination of benefit and risk in the context of product development and clinical practice the OMERACT Executive identified the need to bring together a variety of specialists to define risk. At the Drug Safety Summit held at OMERACT 9, specialists spoke on their given topics and the group considered risk in the context of formally posed questions. The Journal of Rheumatology",
author = "Simon, {Lee S.} and Strand, {C. Vibeke} and Maarten Boers and Brooks, {Peter M.} and David Henry and Tugwell, {Peter S.}",
year = "2009",
month = "9",
doi = "10.3899/jrheum.090590",
language = "English",
volume = "36",
pages = "2110--2113",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology",
number = "9",

}

Simon, LS, Strand, CV, Boers, M, Brooks, PM, Henry, D & Tugwell, PS 2009, 'Observations from the OMERACT Drug Safety Summit, May 2008' Journal of Rheumatology, vol. 36, no. 9, pp. 2110-2113. https://doi.org/10.3899/jrheum.090590

Observations from the OMERACT Drug Safety Summit, May 2008. / Simon, Lee S.; Strand, C. Vibeke; Boers, Maarten; Brooks, Peter M.; Henry, David; Tugwell, Peter S.

In: Journal of Rheumatology, Vol. 36, No. 9, 09.2009, p. 2110-2113.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Observations from the OMERACT Drug Safety Summit, May 2008

AU - Simon, Lee S.

AU - Strand, C. Vibeke

AU - Boers, Maarten

AU - Brooks, Peter M.

AU - Henry, David

AU - Tugwell, Peter S.

PY - 2009/9

Y1 - 2009/9

N2 - Due to mounting concern about determination of benefit and risk in the context of product development and clinical practice the OMERACT Executive identified the need to bring together a variety of specialists to define risk. At the Drug Safety Summit held at OMERACT 9, specialists spoke on their given topics and the group considered risk in the context of formally posed questions. The Journal of Rheumatology

AB - Due to mounting concern about determination of benefit and risk in the context of product development and clinical practice the OMERACT Executive identified the need to bring together a variety of specialists to define risk. At the Drug Safety Summit held at OMERACT 9, specialists spoke on their given topics and the group considered risk in the context of formally posed questions. The Journal of Rheumatology

UR - http://www.scopus.com/inward/record.url?scp=70349230070&partnerID=8YFLogxK

U2 - 10.3899/jrheum.090590

DO - 10.3899/jrheum.090590

M3 - Article

VL - 36

SP - 2110

EP - 2113

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 9

ER -